secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORASURE TECHNOLOGIES INC (OSUR)
CIK:        0001116463
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0000950170-23-020635
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OraSure Q1 record revenue $155M, GAAP EPS $0.37; guides Q2 rev $62-67M
----------------------------------------------------------------------

- Total net revenue $155.0M (+129% YoY); InteliSwab revenue $118.3M (+33% sequential).
- GAAP EPS $0.37, non-GAAP EPS $0.47; cash and short-term investments $112.4M.
- Core business (ex-COVID) revenue $36.6M flat YoY; signed three new molecular partnerships.
- 2Q23 guidance: total revenue $62-67M, InteliSwab $25-30M; cost savings beyond $15M targeted.
- Gross margin 42.5% GAAP, up 200bps sequential; packaging changes expected to save ~$0.50/test.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1116463/000095017023020635/0000950170-23-020635-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1116463/000095017023020635/osur-20230510.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-020635

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer